262 Pharmaco-phenomic modeling of elexacaftor-tezacaftor-ivacaftor–refractory CFTR alleles von Mancinone, R., Gaines, E., Santos, S., Rodgers, J., Sorscher, E., Hartman, J.

Volltext

649 Functional analysis of elexacaftor/tezacaftor/ivacaftor-refractory class II mutations by yeast phenomic profiling von Mancinone, R., Lowe, L., Gaines, E., Santos, S., Rodgers, J., Sorscher, E., Hartman, J.

Volltext

307 Pharmaco-phenomic modeling of premature termination codon and elexacaftor/tezacaftor/ivacaftor-ineligible missense CFTR alleles von Mancinone, R., Gaines, E., Santos, S., McDaniel, A., Cron, R., Rodgers, J., Joshi, D., Hong, J., Oliver, K., Sorscher, E., Hartman, J.

Volltext

581: YOR1 modeling of CFTR nonsense variants to discover effects of genetic factors and sequence context on efficacy of PTC suppression von Gaines, E., Mancinone, R., Laflin, S., Wang, W., Rowe, S., Oliver, K., Mao, Y., Rab, A., Hong, J., Sorscher, E., Hartman, J.

Volltext